OHSU Rare Disease Research Consortium Symposium 2015: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
(4 intermediate revisions by the same user not shown) | |||
Line 36: | Line 36: | ||
| 6:30 to 6:35 | | 6:30 to 6:35 | ||
| [https://www.linkedin.com/in/hoatlin Maureen Hoatlin, Ph.D.,MBA], Associate Professor Biochemistry and Molecular Biology, co-chair OHSU Rare Disease Research Consortium | | [https://www.linkedin.com/in/hoatlin Maureen Hoatlin, Ph.D.,MBA], Associate Professor Biochemistry and Molecular Biology, co-chair OHSU Rare Disease Research Consortium | ||
| OHSU Rare Disease Consortium overview and | | OHSU Rare Disease Consortium overview and objectives of the symposium | ||
|-- | |-- | ||
| 6:35 to 6:45 | | 6:35 to 6:45 | ||
| [http://www.ohsu.edu/xd/research/research-expertise/researchers/?personid=586 Eric Orwoll, M.D.] | | [http://www.ohsu.edu/xd/research/research-expertise/researchers/?personid=586 Eric Orwoll, M.D.]., Professor of Medicine, Brittle Bone Disorder Rare Disease Research Clinical Network | ||
| Osteogenesis imperfecta: a brittle bone disease with well-defined molecular pathologies but limited clinical insights and therapies | | Osteogenesis imperfecta: a brittle bone disease with well-defined molecular pathologies but limited clinical insights and therapies | ||
|-- | |-- | ||
Line 48: | Line 48: | ||
|-- | |-- | ||
| 6:55 to 7:05 | | 6:55 to 7:05 | ||
| [http://www.ohsu.edu/xd/health/services/providers/index.cfm?personID=2057 Evan Shereck, M.D.] | | [http://www.ohsu.edu/xd/health/services/providers/index.cfm?personID=2057 Evan Shereck, M.D.], Associate Professor of Pediatrics | ||
| Overview of the program in Primary Immune Deficiency Treatment Consortium (PIDTC) | | Overview of the program in Primary Immune Deficiency Treatment Consortium (PIDTC) | ||
|-- | |-- | ||
|7:05 to 7:10 | |7:05 to 7:10 | ||
| [http://www.ohsu.edu/xd/research/centers-institutes/stem-cell-center/faculty/markus-grompe.cfm Markus Grompe, M.D.] | | [http://www.ohsu.edu/xd/research/centers-institutes/stem-cell-center/faculty/markus-grompe.cfm Markus Grompe, M.D.], Fanconi anemia Program Project P.I., Professor, Departments of Pediatrics and Molecular and Medical Genetics, Director, Papé Family Pediatric Research Institute | ||
| Program in Fanconi anemia | | Program in Fanconi anemia | ||
|-- | |-- | ||
| 7:10 to 7:20 | | 7:10 to 7:20 | ||
| [http://www.ohsu.edu/xd/education/schools/school-of-medicine/departments/basic-science-departments/molecular-and-medical-genetics/people/primary-faculty/cary-harding.cfm Cary Harding, M.D.] | | [http://www.ohsu.edu/xd/education/schools/school-of-medicine/departments/basic-science-departments/molecular-and-medical-genetics/people/primary-faculty/cary-harding.cfm Cary Harding, M.D.], Professor of Molecular and Medical Genetics and Pediatrics | ||
| Clinical trials in inborn errrors of amino acid and fatty acid metabolism | | Clinical trials in inborn errrors of amino acid and fatty acid metabolism | ||
|-- | |-- |
Revision as of 20:15, 1 April 2015
April 7, 2015, from 4-8:30 pm at OHSU in the Joseph Vey Conference Center
General InfoSchedule
|